Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,468 | 4,850 | N/A | N/A | 8,354 |
| Depreciation Amortization | 2,192 | 2,050 | N/A | N/A | 1,715 |
| Income taxes - deferred | -81 | N/A | N/A | N/A | N/A |
| Accounts receivable | 1 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 21 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,534 | 2,030 | N/A | N/A | 728 |
| Other Operating Activity | -34 | 530 | 0 | 0 | 311 |
| Operating Cash Flow | $9,101 | $9,460 | $N/A | $N/A | $11,108 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -683 | -460 | N/A | N/A | -2,074 |
| Net Acquisitions | N/A | -4,180 | N/A | N/A | 0 |
| Purchase Sale Intangibles | -2 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -2 | -320 | 0 | 0 | -2,468 |
| Investing Cash Flow | $-685 | $-4,960 | $N/A | $N/A | $-4,542 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,071 | N/A | N/A | N/A | N/A |
| Debt Repayment | -6,231 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 98 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -12,058 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -4,090 | 0 | 0 | -3,080 |
| Financing Cash Flow | $-9,120 | $-4,090 | $N/A | $N/A | $-3,080 |
| Exchange Rate Effect | -16 | 10 | N/A | N/A | 0 |
| Beginning Cash Position | 1,367 | 950 | N/A | N/A | 1,579 |
| End Cash Position | 647 | 1,360 | N/A | N/A | 5,065 |
| Net Cash Flow | $-720 | $410 | $N/A | $N/A | $3,486 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,101 | 9,460 | N/A | N/A | 11,108 |
| Capital Expenditure | -684 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 8,417 | 9,460 | 0 | 0 | 11,108 |